- Home
- QTTB vs KFFB Comparison
QTTB vs KFFB Comparison
Compare QTTB & KFFB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | QTTB | KFFB |
|---|---|---|
| Founded | 2015 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 80.0M | 39.2M |
| IPO Year | 2018 | 2004 |
Fundamental Metrics
Financial Performance| Metric | QTTB | KFFB |
|---|---|---|
| Price | $6.20 | $4.78 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $13.00 | N/A |
| AVG Volume (30 Days) | ★ 325.4K | 1.5K |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 136.78 | 109.52 |
| EPS | ★ 2.42 | 0.08 |
| Revenue | ★ $53,737,000.00 | $15,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $2.52 | $59.75 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.40 | $1.96 |
| 52 Week High | $8.05 | $4.98 |
Technical Indicators
Market Signals| Indicator | QTTB | KFFB |
|---|---|---|
| Relative Strength Index (RSI) | 53.94 | 50.82 |
| Support Level | $5.51 | $4.48 |
| Resistance Level | $6.37 | $4.89 |
| Average True Range (ATR) | 0.76 | 0.15 |
| MACD | -0.12 | 0.01 |
| Stochastic Oscillator | 42.46 | 51.68 |
Price Performance
Historical ComparisonAbout QTTB Q32 Bio Inc.
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to restore healthy immune balance in patients with alopecia areata (AA) and other autoimmune and inflammatory diseases driven by immune dysfunction. Its product candidate, bempikibart (ADX 914), is a fully human anti-interleukin 7 receptor alpha (IL-7R) antagonist monoclonal antibody designed to block signaling mediated by interleukin 7 (IL 7) and thymic stromal lymphopoietin (TSLP) and re-regulate adaptive immune function. The company has completed two Phase 2a clinical trials evaluating bempikibart, SIGNAL AA Part A for the treatment of alopecia areata and SIGNAL AD for the treatment of atopic dermatitis (AD).
About KFFB Kentucky First Federal Bancorp
Kentucky First Federal Bancorp is a holding company. The company, through its subsidiaries, is engaged mainly in the business of accepting deposits from the general public and using such funds to originate loans secured by first mortgages on owner-occupied, residential real estate and other loans secured by real estate. Its primary products and services include Residential mortgage loans, Multi-family loans, Construction loans, and types of deposits etc. The company mainly operates in Perry, Franklin, Boyle, and Garrard and surrounding counties in Kentucky, USA.